Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges - Poll - MDSpire

Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges

  • By

  • Shuyu Ren

  • Fangfang Pan

  • Jie Jin

  • May 14, 2026

  • 0 min

Share

Original Source(s)

Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges

  • by Shuyu Ren, Fangfang Pan, Jie Jin

  • May 14, 2026

Related Content

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors